Metraipolis › archive › dc_5020b665fde6

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas — Europe PMC PMID:35130560

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35130560
DOI
10.1038/s41586-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-08T04:51:45.510Z
SHA-256 of the archived text
33ea5784e0ff98db5840fc6a136944db02c1876d3dda458cca1b955118e98f93
Stable URL of this page
https://metraipolis.com/documento/dc_5020b665fde6

How to cite

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas — Europe PMC PMID:35130560 — Europe PMC (en), https://europepmc.org/article/MED/35130560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5020b665fde6 (Metraipolis archive dc_5020b665fde6, sha256 33ea5784e0ff98db5840fc6a136944db02c1876d3dda458cca1b955118e98f93)
BibTeX
@misc{dc5020b665fde6,
  title = {GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas — Europe PMC PMID:35130560},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35130560},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5020b665fde6; sha256 33ea5784e0ff98db5840fc6a136944db02c1876d3dda458cca1b955118e98f93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35130560. Agents can read the archived copy with the MCP tool read_document.